|4Jul 3, 5:04 PM ET

Furey John 4

4 · Adaptimmune Therapeutics PLC · Filed Jul 3, 2023

Insider Transaction Report

Form 4
Period: 2023-07-03
Furey John
Director
Transactions
  • Award

    Option to purchase Ordinary Shares

    2023-07-03+500,000500,000 total
    Exercise: $0.16From: 2024-07-03Exp: 2033-07-03Ordinary Shares (500,000 underlying)
Footnotes (1)
  • [F1]The exercise price was converted from GBP0.12 based on an exchange rate of $U.S. 1.270841 to GBP1.00. The actual exercise price will be the pounds sterling amount.

Documents

1 file
  • 4
    tm2320409-6_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT